HSPA6 is also a putative target of endothelial nitric oxide synthase and is involved in the highly clinically relevant inhibition of vascular smooth muscle cell (VSMC) proliferation, which can repair vessels in human atherosclerosis (McCullagh et al., 2016). Here, HSPA6 is linked to atherosclerosis.